What’s Hot, Not & Doing
Brought to you by TSN Contributor & Wealth Advisor Nick Kelso
What’s Hot – AVJ, KRR, EPY, TMG, LV1, CRI & PME
What’s Not – PAR
What’s Hot
AVJ – AVJennings Limited today closed up 88% to finish at 62c on $5m stock traded. The reason they were up today was because they announced the receipt of a non-binding indicative proposal (NBIO) to be acquired by Proprium Capital Partners for 67c in cash.
Proprium Capital Partners is a specialist real estate investment manager with approximately A$4 billion in assets under management, including AVID, which is one of the group’s flagship investments.
AVID is one of the largest privately held residential developers in Australia with a portfolio of projects that includes residential master planned communities, resort communities, completed homes and apartments.
KRR – King River Resources Limited today closed up 38% to finish at 1.8c on $230k stock traded. There was no news out today but earlier this month they announced assay results from its Kurundi Project located in the NT.
Drilling identified a new high grade gold zone 250m south of the central main workings with assays returning up to 9m @ 1.62g/t Au from 49m including 1m @ 12.75g/t Au from 53m.
KRR will follow up on the new high-grade zone and test deeper beneath the central main structure.
Drilling has also intersected a possible new style of mineralisation on a porphyry-basalt contact with highlights of 2m @ 10.93g/t Au from 51m.
EPY – Earlypay Limited today closed up 27% to finish at 21c on $140k stock traded. The reason they were up today was because they released a FY25 trading outlook.
Earlypay is targeting FY25 underlying EPS (earnings per share) of 2.2c which is a 28% gain on the previous corresponding period.
New originations have started strongly in FY25 across both the invoice finance and equipment finance segments.
Earnings are expected to be weighted towards H2FY25 due to the lower starting base for FIU (funds in use) at the beginning of the year and lower interest expense cost after the repayment of the corporate loan expected in Q3FY25.
TMG – Trigg Minerals Limited today closed up 14% to finish at 4c on $1.2m stock traded. There was no news out today but earlier this month they announced high-resolution satellite imagery analysis was completed over the recently acquired Achilles Antimony Project located in NSW.
Achilles hosts the globally significant high-grade Wild Cattle Creek deposit which features some of Australia’s thickest and highest-grade antimony intersections including 10.7m @ 14.24% Sb.
The analysis results have identified a substantial number of exploration targets, including 30 new targets and several previously noted by the former owner.
LV1 – Live Verdure Limited today closed up 12% to finish at 94.5c on $600k stock traded. There was no news out today but last month they released its quarterly results which highlighted that its strategic partner Decidr.ai had secured multiple new contracts posting its first revenue result.
Decidr entered into strategic partnerships with CareerOne and ELMO Software, both respectively a leading job board and provider of cloud-based HR and payroll software, to integrate its AI-powered recruitment tools into ELMO’s platform.
LV1 has also deepened its engagement with Decidr agreeing to pursue a more comprehensive licensing strategy, allowing the technology to be deployed on a larger scale.
CRI – Critica Limited today closed up 10% to finish at 1.1c on $180k stock traded. There was no news out today but yesterday they announced the final assay results from the Jupiter Project within the broader Brothers Clay-Hosted REE Project located in WA.
Mineral resource drilling confirmed that the high-grade rare earth mineralisation at Jupiter demonstrated excellent continuity.
Critica has been able to complete circa 40,000 meters of drilling in less than 18 months along with metallurgical test work which is underway.
Jupiter boasts remarkably consistent, rare-earth mineralization over the entire 40km2 project area, broad, high-grade zones of 20m-30m widths possess grades over 2,000 ppm of total rare earth oxides (TREO).
PME – Pro Medicus Limited today closed up 9% to finish at $248.18 on $90m stock traded. The reason they were up today was because they announced a $330m 10-year contract was signed with Trinity Health.
Trinity Health is one of the largest not-for-profit health care systems in the US with 93 hospitals and more than 127,000 colleagues.
Based on a transactional licensing model, the contract will see its cloud-based Visage 7 Enterprise Imaging Platform implemented throughout Trinity to provide a unified diagnostic imaging platform.
What’s Not
PAR – Paradigm Biopharmaceuticals Limited today closed down 21% to finish at 45.5c on $4.3m stock traded. The reason they were down today was because they announced the conclusion of the FDA’s 30-day review period for its phase 3 pivotal clinical trial protocol (PARA_OA_012).
With no substantive questions or concerns raised by the FDA, Paradigm can proceed with its pivotal phase 3 clinical trial, utilising the 2mg/kg twice weekly iPPS dosing regimen.
Preparations for the pivotal phase 3 clinical trial are well advanced, Paradigm remains on track to commence patient enrolment in Q1CY25.
Rats Rant – IMPORTANT INFORMATION
The idea of this report is to be informative and hopefully point out some stocks that you wouldn’t ordinarily have seen during the day, maybe even have a laugh too.This report IS NOT personal advice. Sanlam Private Wealth Pty Ltd DOES NOT PROVIDE personal advice, Sanlam Private Wealth provides General Financial Product Advice.All advice included in The Rat’s Rant is General Advice. Please refer to the General Advice Warning. The views expressed in this report are my views and may not necessarily reflect the same views as Sanlam Private Wealth.It is very important to refer to the ASX website for information on any companies / stock that are contained in this report and as always please consult your financial adviser before acting.
Important Notice
Rat Consulting Pty Ltd (ABN 81 148 181 588 ) Authorised Representative (No 001281456) of Sanlam Private Wealth Ltd (ABN 18 136 960 775) holder of Australian Financial Services Licence (AFSL 337 927).